Ds Healthcare Group, Revenue Growth Rates (DSKX), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Ds Healthcare Group, Inc.  (DSKX)
 

DSKX's Revenue Growth by Quarter and Year

Ds Healthcare Group,'s Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DSKX Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
4th Quarter December -
3rd Quarter September -
2nd Quarter June 2.23
1st Quarter March 2.09
FY 4.32

DSKXs Annual Revenue
Ds Healthcare Group,'s Revenue in the fiscal year 2016 $ 0.00 millions
Ds Healthcare Group,'s Revenue in the fiscal year 2015 $ 11.78 millions
Ds Healthcare Group,'s Revenue in the fiscal year 2014 $ 13.41 millions
Ds Healthcare Group,'s Revenue in the fiscal year 2013 $ 13.65 millions
Ds Healthcare Group,'s Revenue in the fiscal year 2012 $ 11.22 millions




DSKX Revenue second quarter 2017 Y/Y Growth Comment
Ds Healthcare Group, Inc. reported drop in Revenue in the second quarter 2017 by -53.92% to $ 2.23 millions, from the same quarter in 2016.
The fall in the second quarter 2017 Ds Healthcare Group, Inc.'s Revenue compares unfavorably to the Company's average Revenue increase of 12.8%.

Looking into second quarter 2017 results within Biotechnology & Pharmaceuticals industry 51 other companies have achieved higher Revenue growth. While Ds Healthcare Group, Inc.' s Revenue meltdown of -53.92% ranks overall at the positon no. 4072 in the second quarter 2017.


DSKX Revenue ( Y/Y Growth %) 2017
 2016 2015 2014
4th Quarter December - 84.52 % -54.72 % 21.64 %
3rd Quarter September - -14.1 % -4.88 % 2.5 %
2nd Quarter June -53.92 % 46.67 % -11.76 % 9.04 %
1st Quarter March -10.3 % -13.7 % 0.75 % -32.49 %
FY   - 19.91 % -19.46 % -

Financial Statements
Ds Healthcare Group,'s second quarter 2017 Revenue $ 2.23 millions DSKX's Income Statement
Ds Healthcare Group,'s second quarter 2016 Revenue $ 4.84 millions Quarterly DSKX's Income Statement


DSKX Revenue (Quarter on Quarter Growth %)

 2017
 2016 2015 2014
4th Quarter December - 15.67 % -46.15 % 13.11 %
3rd Quarter September - -44.63 % -5.45 % -12.3 %
2nd Quarter June 6.71 % 107.73 % 22.22 % 39.55 %
1st Quarter March -32.58 % 38.69 % -27.22 % -12.13 %
FY (Year on Year)   - 19.91 % -19.46 % -


Back to DSKX Growth rate Comparisons >> Back to DSKX Growth rate Comparisons >>


Revenue second quarter 2017 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #52
Healthcare Sector #505
Overall #4072

Revenue Y/Y Growth Statistics
High Average Low
99.87 % 12.8 % -54.77 %
(Mar 31 2013)   (Jun 30 2017)
Revenue second quarter 2017 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #52
Healthcare Sector #505
Overall #4072
Revenue Y/Y Growth Statistics
High Average Low
99.87 % 12.8 % -54.77 %
(Mar 31 2013)   (Jun 30 2017)

Revenue by Quarter for the Fiscal Years 2014, 2015, 2016, 2017

Ds Healthcare Group,'s Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
108.38 % -1.87 % -100 %
(Jun 30 2016)  


DSKX's II. Quarter Q/Q Revenue Comment
Ds Healthcare Group, Inc. achieved in the II. Quarter 2017 above company average sequential Revenue increase of 6.71%, to $ 2.23 millions, from $2.09 millions in the first quarter.

Within Biotechnology & Pharmaceuticals industry 33 other companies have achieved higher Revenue quarter on quarter growth. While Ds Healthcare Group,'s Revenue growth quarter on quarter, overall rank is 1839.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #34
Healthcare Sector #292
Overall #1839
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #34
Healthcare Sector #292
Overall #1839
Revenue Q/Q Growth Statistics
High Average Low
108.38 % -1.87 % -100 %
(Jun 30 2016)  


DSKX's II. Quarter Q/Q Revenue Comment
Ds Healthcare Group, Inc. achieved in the II. Quarter 2017 above company average sequential Revenue increase of 6.71%, to $ 2.23 millions, from $2.09 millions in the first quarter.

Within Biotechnology & Pharmaceuticals industry 33 other companies have achieved higher Revenue quarter on quarter growth. While Ds Healthcare Group,'s Revenue growth quarter on quarter, overall rank is 1839.


Ds Healthcare Group,'s 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2017)		 12 Months Ending
(Mar 31 2017)		 12 Months Ending
(Dec 31 2016)		 12 Months Ending
(Sep 30 2016)		 12 Months Ending
(Jun 30 2016)
Cumulative Revenue 12 Months Ending $ 10.10 $ 12.72 $ 12.95 $ 11.52 $ 11.97
Y / Y Revenue Growth (TTM) -15.58 % 21.97 % 19.89 % -10.19 % -7.86 %
Year on Year Revenue Growth Overall Ranking # 2935 # 1670 # 1670 # 1456 # 1429
Seqeuential Revenue Change (TTM) -20.56 % -1.78 % 12.37 % -3.71 % 14.78 %
Seq. Revenue Growth (TTM) Overall Ranking # 2461 # 2964 # 0 # 2900 # 2651


Cumulative Revenue growth Comment
For the 12 months ended Jun 30 2017 Ds Healthcare Group, reported a fall in Revenue by -15.58% year on year, to $10 millions, compare to the 21.97% growth at Mar 31 2017.

In the Healthcare sector 335 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1670 to 2935.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 27
Healthcare Sector # 336
Overall # 2935

Revenue TTM Y/Y Growth Statistics
High Average Low
21.62 %
 0.31 %
-18.92 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 27
Sector # 285
S&P 500 # 2461
Cumulative Revenue growth Comment
For the 12 months ended Jun 30 2017 Ds Healthcare Group, reported a fall in Revenue by -15.58% year on year, to $10 millions, compare to the 21.97% growth at Mar 31 2017.

In the Healthcare sector 335 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1670 to 2935.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 27
Healthcare Sector # 336
Overall # 2935

Revenue TTM Y/Y Growth Statistics
High Average Low
21.62 %
0.31 %
-18.92 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 27
Sector # 285
S&P 500 # 2461




Other Revenue Growth
Biotechnology & Pharmaceuticals Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
DSKX's Revenue Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue fall for the quarter ending Jun 30 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2017
Ufp Technologies Inc -0.04%$ -0.042 millions
Fate Therapeutics Inc -0.10%$ -0.097 millions
Psychemedics Corporation-0.17%$ -0.165 millions
Avanos Medical Inc -0.20%$ -0.200 millions
Xtant Medical Holdings Inc -0.25%$ -0.249 millions
Hanger inc.-0.40%$ -0.405 millions
Surgery Partners Inc -0.46%$ -0.458 millions
Ocular Therapeutix Inc -0.68%$ -0.680 millions
Tenet Healthcare Corp-0.90%$ -0.900 millions
Meridian Bioscience Inc -1.04%$ -1.036 millions
Integrated Biopharma Inc-1.21%$ -1.212 millions
Genmark Diagnostics Inc -1.22%$ -1.223 millions
Carlisle Companies Incorporated-1.30%$ -1.304 millions
Cardiff Oncology Inc -1.34%$ -1.343 millions
Rockwell Medical inc -1.56%$ -1.557 millions
Cas Medical Systems Inc-1.66%$ -1.660 millions
Vaso Corporation-1.98%$ -1.982 millions
Valeritas Holdings Inc.-1.99%$ -1.986 millions
Societal Cdmo Inc -2.00%$ -1.997 millions
Syneos Health Inc -2.13%$ -2.130 millions
Quorum Health Corporation-2.16%$ -2.165 millions
Quest Diagnostics Inc-2.20%$ -2.204 millions
Quidelortho Corp-2.21%$ -2.213 millions
Bio rad Laboratories Inc -2.34%$ -2.344 millions
China Biologic Products Holdings Inc -2.34%$ -2.344 millions
Msa Safety Inc-2.44%$ -2.440 millions
Dentsply Sirona Inc -2.87%$ -2.867 millions
Pacific Biosciences Of California Inc -3.25%$ -3.249 millions
Pfenex Inc -3.38%$ -3.381 millions
T2 Biosystems Inc -3.43%$ -3.434 millions


About Ds Healthcare Group, Revenue Growth Rates (DSKX), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.